Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
Expanded access is temporarily not available for this treatment.
Study NCT00870636
Information provided by Children's Hospital Los Angeles
First Received on March 26, 2009.
Last Updated on March 27, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
